AAAAAA
Results: 26-50/51
Authors:
OKAMOTO S
TAKAHASHI S
TANOSAKI R
SAKAMAKI H
ONOZAWA Y
OH H
MIYAWAKI S
KIMURA Y
TOYAMA K
IKEDA Y
ASANO S
Citation: S. Okamoto et al., GRANISETRON IN THE PREVENTION OF VOMITING INDUCED BY CONDITIONING FORSTEM-CELL TRANSPLANTATION - A PROSPECTIVE RANDOMIZED STUDY, Bone marrow transplantation, 17(5), 1996, pp. 679-683
Authors:
GOTO H
YUASA K
SAKAMAKI H
NAKATA K
KOMURO I
IGUCHI M
OKAMURA T
IEKI R
TANIKAWA S
AKIYAMA H
ONOZAWA Y
MOCHIDA Y
Citation: H. Goto et al., RAPID DETECTION OF CYTOMEGALOVIRUS PNEUMONIA IN RECIPIENTS OF BONE-MARROW TRANSPLANT - EVALUATION AND COMPARISON OF 5 SURVEY METHODS FOR BRONCHOALVEOLAR LAVAGE FLUID, Bone marrow transplantation, 17(5), 1996, pp. 855-860
Authors:
MATSUMOTO K
YAMASAKI H
AKAZAWA S
SAKAMAKI H
ISHIBASHI M
ABIRU N
UOTANI S
MATSUO H
YAMAGUCHI Y
TOKUYAMA K
NAGATAKI S
Citation: K. Matsumoto et al., HIGH-DOSE BUT NOT LOW-DOSE DEXAMETHASONE IMPAIRS GLUCOSE-TOLERANCE BYINDUCING COMPENSATORY FAILURE OF PANCREATIC BETA-CELLS IN NORMAL MEN, The Journal of clinical endocrinology and metabolism, 81(7), 1996, pp. 2621-2626
Authors:
OGATA K
YOKOSE N
AN E
KAMIKUBO K
TAMURA H
DAN K
SAKAMAKI H
ONOZAWA Y
HAMAGUCHI H
NOMURA T
Citation: K. Ogata et al., PLASMA SOLUBLE INTERLEUKIN-2 RECEPTOR LEVEL IN PATIENTS WITH PRIMARY MYELODYSPLASTIC SYNDROMES - A RELATIONSHIP WITH DISEASE SUBTYPE AND CLINICAL OUTCOME, British Journal of Haematology, 93(1), 1996, pp. 45-52
Authors:
OHNO R
ASOU N
KANAMARU A
ADACHI K
MIYAWAKI S
KAGEYAMA S
HIRAOKA A
OHMOTO E
SAKAMAKI H
TSUBAKI K
SAITO K
KURIYAMA K
OH H
KITANO Y
Citation: R. Ohno et al., JALSG-AML92 FOR NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA (APL) WITH ALL-TRANS-RETINOIC ACID (ATRA) FOLLOWED BY INTENSIVE CONSOLIDATION ACID MAINTENANCE INTENSIFICATION CHEMOTHERAPY - PROGNOSTIC FACTORS FORREMISSION AND SURVIVAL/, Blood, 88(10), 1996, pp. 1157-1157
Authors:
AKIYAMA H
TANIKAWA S
TAKAMOTO S
SAKAMAKI H
SASAKI T
ONOZAWA Y
Citation: H. Akiyama et al., RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHEPO) ADMINISTRATION MARROW DONORS, International journal of hematology, 62(3), 1995, pp. 145-149
Authors:
ISHIBASHI M
AKAZAWA S
SAKAMAKI H
KONDO T
NAGATAKI S
Citation: M. Ishibashi et al., ANTIOXIDANT SYSTEM IN RAT EMBRYO DURING EARLY ORGANOGENESIS AND EXPOSURE TO OXIDATIVE STRESS, Diabetologia, 38, 1995, pp. 21-21
Authors:
AKAZAWA S
TROCINO RA
ISHIBASHI M
AKAZAWA M
SAKAMAKI H
MATSUMOTO K
YAMASAKI H
YAMAGUCHI Y
KONDO T
NAGATAKI S
Citation: S. Akazawa et al., SIGNIFICANCE OF GLUTATHIONE-DEPENDENT ANTIOXIDANT SYSTEM IN HYPERGLYCEMIA-INDUCED EMBRYONIC MALFORMATIONS, Diabetologia, 38, 1995, pp. 281-281
Authors:
SAKAMAKI H
KAMEDA N
IWADARE T
ICHINOHE Y
Citation: H. Sakamaki et al., A NOVEL METHYLATION OF ALLYLIC ALCOHOLS USING CIS-DICHLOROBIS (TRIPHENYLPHOSPHINE) PLATINUM(II)-TIN(II) CHLORIDE DIHYDRATE COMPLEX CATALYST, Bulletin of the Chemical Society of Japan, 68(12), 1995, pp. 3491-3495
Authors:
TAKESHITA A
SAKAMAKI H
MIYAWAKI S
KOBAYASHI T
KURIYAMA K
YAMADA O
OH H
TAKENAKA T
ASOU N
OHNO R
Citation: A. Takeshita et al., SIGNIFICANT REDUCTION OF MEDICAL COSTS BY DIFFERENTIATION THERAPY WITH ALL-TRANS-RETINOIC ACID DURING REMISSION INDUCTION OF NEWLY-DIAGNOSED PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA, Cancer, 76(4), 1995, pp. 602-608
Authors:
OGATA K
TAMURA H
YOKOSE N
AN E
DAN K
HAMAGUCHI H
SAKAMAKI H
ONOZAWA Y
CLARK SC
NOMURA T
Citation: K. Ogata et al., EFFECTS OF INTERLEUKIN-12 ON NATURAL-KILLER-CELL CYTOTOXICITY AND THEPRODUCTION OF INTERFERON-GAMMA AND TUMOR-NECROSIS-FACTOR-ALPHA IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES, British Journal of Haematology, 90(1), 1995, pp. 15-21
Authors:
KANDA Y
AKIYAMA H
TANIKAWA S
SAKAMAKI H
SASAKI T
TAKAMOTO S
ONOZAWA Y
Citation: Y. Kanda et al., BUSULFAN, CYCLOPHOSPHAMIDE, ETOPOSIDE AND GRANULOCYTE-COLONY-STIMULATING FACTOR (BU CY/ETP/G-CSF) COMBINATION AS A PREPARATIVE REGIMEN FOR BONE-MARROW TRANSPLANTATION (BMT) IN HIGH-RISK LEUKEMIA PATIENTS - A PHASE-1 STUDY/, Blood, 86(10), 1995, pp. 3792-3792
Authors:
KANAMARU A
TAKEMOTO Y
TANIMOTO M
MURAKAMI H
ASOU N
KOBAYASHI T
KURIYAMA K
OHMOTO E
SAKAMAKI H
TSUBAKI K
HIRAOKA A
YAMADA O
OH H
SAITO K
MATSUDA S
MINATO K
UEDA T
OHNO R
Citation: A. Kanamaru et al., ALL-TRANS-RETINOIC ACID FOR THE TREATMENT OF NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA, Blood, 85(5), 1995, pp. 1202-1206
Authors:
SAKAMAKI H
KIMURA Y
NAGUMO M
Citation: H. Sakamaki et al., BIOLOGICAL AND MORPHOLOGICAL-CHARACTERISTICS OF A TRANSPLANTED CARTILAGINOUS TUMOR-DERIVED FROM A HUMAN OSTEOGENIC-SARCOMA, Journal of oral pathology & medicine, 23(7), 1994, pp. 316-323
Authors:
OHNO R
OHNISHI K
TAKESHITA A
TANIMOTO M
MURAKAMI H
KANAMARU A
ASOU N
KOBAYASHI T
KURIYAMA K
OHMOTO E
SAKAMAKI H
TSUBAKI K
HIRAOKA A
YAMADA O
OH H
FURUSAWA S
MATSUDA S
NAOE T
Citation: R. Ohno et al., ALL-TRANS-RETINOIC ACID THERAPY IN RELAPSED REFRACTORY OR NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA (APL) IN JAPAN, Leukemia, 8, 1994, pp. 64-69
Authors:
OHASHI K
AKIYAMA H
TAKAMOTO S
TANIKAWA S
SAKAMAKI H
ONOZAWA Y
Citation: K. Ohashi et al., TREATMENT OF PURE RED-CELL APLASIA AFTER MAJOR ABO-INCOMPATIBLE BONE-MARROW TRANSPLANTATION RESISTANT TO ERYTHROPOIETIN, Bone marrow transplantation, 13(3), 1994, pp. 335-336
Authors:
YOKOSE N
OGATA K
ITO T
AN EM
TAMURA H
DAN KZ
HAMAGUCHI H
SAKAMAKI H
ONOZAWA Y
NOMURA T
Citation: N. Yokose et al., ELEVATED PLASMA SOLUBLE INTERLEUKIN-2 RECEPTOR LEVEL CORRELATES WITH DEFECTIVE NATURAL-KILLER AND CD8-CELLS IN MYELODYSPLASTIC SYNDROMES( T), Leukemia research, 18(10), 1994, pp. 777-782
Authors:
OGATA K
FUJII H
YOKOSE N
AN E
TAMURA H
KAMIKUBO K
DAN K
HAMAGUCHI H
SAKAMAKI H
ONOZAWA Y
NOMURA T
Citation: K. Ogata et al., DEFECTIVE NATURAL-KILLER (NK) CELL-MEDIATED CYTOTOXICITY DOES NOT IMPLY CLONAL INVOLVEMENT OF NK CELLS IN MYELODYSPLASTIC SYNDROMES, British Journal of Haematology, 87(2), 1994, pp. 396-398
Authors:
OGATA K
YOKOSE N
ITO T
AN E
TAMURA H
DAN K
HAMAGUCHI H
SAKAMAKI H
Citation: K. Ogata et al., ASSESSMENT OF THERAPEUTIC POTENTIAL OF INTERLEUKIN-2 FOR MYELODYSPLASTIC SYNDROMES, British Journal of Haematology, 86(3), 1994, pp. 562-567
Authors:
KOBAYASHI T
MIYAWAKI S
TANIMOTO M
KURIYAMA K
MURAKAMI H
YOSHIDA M
KODERA Y
MINATO K
TSUBAKI K
OHMOTO E
OH H
JINNAI I
SAKAMAKI H
HIRAOKA A
KANAMARU A
TAKAHASHI I
FURUSAWA S
NAOE T
YAMADA O
ASOU N
NISHIKAWA K
OKABE K
OGURA M
TANAKA M
OHNO R
Citation: T. Kobayashi et al., RANDOMIZED TRIAL BETWEEN BEHENOYL CYTARABINE (BHAC) OR CYTARABINE IN COMBINATION CHEMOTHERAPY OF ADULT ACUTE MYELOID-LEUKEMIA (AML) (JALSG-AML89 PROTOCOL) AND ANALYSIS OF PROGNOSTIC FACTORS, Blood, 84(10), 1994, pp. 10000146-10000146
Authors:
AKIYAMA H
TANIKAWA S
TAKAMOTO S
SAKAMAKI H
SASAKI T
ONOZAWA Y
Citation: H. Akiyama et al., RECOMBINANT-HUMAN-ERYTHROPOIETIN (EPO) ADMINISTRATION TO MARROW DONORS, Blood, 84(10), 1994, pp. 10000732-10000732
Authors:
AKIYAMA H
MORI S
TANIKAWA S
SAKAMAKI H
ONOZAWA Y
Citation: H. Akiyama et al., FLUCONAZOLE VERSUS ORAL AMPHOTERICIN-B IN PREVENTING FUNGAL INFECTIONIN CHEMOTHERAPY-INDUCED NEUTROPENIC PATIENTS WITH HEMATOLOGICAL MALIGNANCIES, Mycoses, 36(11-12), 1993, pp. 373-378
Authors:
JONES SJ
GRAY C
SAKAMAKI H
ARORA M
BOYDE A
GOURDIE R
GREEN C
Citation: Sj. Jones et al., THE INCIDENCE AND SIZE OF GAP-JUNCTIONS BETWEEN THE BONE-CELLS IN RATCALVARIA, Anatomy and embryology, 187(4), 1993, pp. 343-352
Authors:
MORISHIMA Y
MIYAMURA K
KOJIMA S
UEDA R
MORISHITA Y
SAO H
TANIMOTO M
OHNO R
SOBUE R
HIRANO M
SAKAMAKI H
TAKAMOTO S
IMAI K
ONOZAWA Y
YOKOMAKU S
KATO Y
TSUZUKI S
AKATSUKA Y
MINAMI S
MATSUYAMA T
KODERA Y
TAKAHASHI T
SAITO H
Citation: Y. Morishima et al., AUTOLOGOUS BMT IN HIGH-RISK PATIENTS WITH CALLA-POSITIVE ALL - POSSIBLE EFFICACY OF EXVIVO MARROW LEUKEMIA-CELL PURGING WITH MONOCLONAL-ANTIBODIES AND COMPLEMENT, Bone marrow transplantation, 11(4), 1993, pp. 255-259
Authors:
NOZUE A
SAKAMAKI H
SAITA Y
OKUBO T
Citation: A. Nozue et al., 2-STEP AGING TREATMENT FOR LOWERING OF SU SCEPTIBILITY TO HYDROGEN EMBRITTLEMENT OF TI-15V-3CR-3SN-3AL ALLOY, Nippon Kinzoku Gakkaishi, 57(10), 1993, pp. 1136-1140